Iminostilbene

Description

1. Product Overview

Iminostilbene is a heterocyclic aromatic compound widely used as a key intermediate in the pharmaceutical and specialty chemical industries. It serves as a critical building block in the synthesis of active pharmaceutical ingredients (APIs), particularly for anticonvulsant and mood-stabilizing drugs. The primary value proposition lies in its high reactivity and structural compatibility for downstream chemical transformations, enabling efficient and scalable synthesis pathways. Strategically, iminostilbene is essential in ensuring consistent API production, supporting global pharmaceutical supply chains, and maintaining cost-effective drug manufacturing processes.

2. Key Specifications & Technical Characteristics

• Chemical Composition:
  • Iminostilbene (C₁₄H₁₁N)
  • Trace organic impurities depending on synthesis route
• Purity Level / Grade:
  • Industrial / pharmaceutical intermediate grade
  • Typical purity: ≥ 98% (batch-dependent)
  • High-performance liquid chromatography (HPLC) analysis available
• Physical Characteristics:
  • Solid form (crystalline powder or flakes)
  • Color: Off-white to light yellow
  • Odor: Mild aromatic
  • Melting point: ~195–200°C
  • Density: Approx. 1.1–1.2 g/cm³
• Packaging Options:
  • Fiber drums (25 kg or 50 kg)
  • HDPE-lined bags
  • Custom bulk packaging available upon request
• Shelf Life:
  • Typically 24 months under dry, sealed storage conditions
  • Store in a cool, moisture-free environment away from direct light

3. Core Industrial Applications

Primary Industries:

• Pharmaceutical manufacturing
• Specialty chemicals production
• Fine chemical synthesis

Operational Use Cases:

• Intermediate in the synthesis of anticonvulsant APIs (e.g., carbamazepine derivatives)
• Precursor for heterocyclic compound development
• Building block for advanced organic synthesis in specialty chemicals

Performance & Cost Advantages:
Iminostilbene offers high chemical stability and reactivity, enabling efficient conversion in multi-step synthesis processes. Its well-defined structure reduces side reactions, improving yield and lowering purification costs. Compared to alternative intermediates, it delivers superior process reliability, making it a preferred choice for pharmaceutical-grade manufacturing.

4. Competitive Advantages

• Quality Consistency: Controlled synthesis ensuring high purity and batch-to-batch uniformity
• Supply Reliability: Scalable production aligned with pharmaceutical industry demand cycles
• Logistics Capability: Secure packaging and global distribution compliance
• Price Competitiveness: Optimized production routes delivering cost-effective supply
• Sustainability Benefits: Efficient synthesis pathways minimizing waste generation
• Technical Documentation: Comprehensive COA, SDS, and regulatory support documentation available

Positioned as a strategic sourcing component, iminostilbene enables manufacturers to maintain consistent API quality, streamline production efficiency, and strengthen supply chain resilience in highly regulated pharmaceutical markets.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT
• Loading Capacity (MT per container): Approximately 18–20 MT per 20’ container (depending on packaging configuration)